Statistics for Lava Therapeutics B.V. (id:8429 LVTX)

Valuation metrics

Market cap

39.97M

Enterprise value

-39,744,664.00

Trailing P/E (ttm)

-0.97

Forward P/E

-0.78

PEG ratio

-0.78

Price/Sales (ttm)

5.40

Price/Book (mrq)

0.93

Enterprise Value/Revenue

-5.37

Enterprise Value/EBITDA

1.48

Overview

Shares outstanding

26.30M

Float

12.09M

Shares short

19.11K

% Held by insiders

0.29%

% Held by institutions

0.32%

Average volume (10 days)

39.94K

Average volume (90 days)

Price summary

52-Week low

1.35

52-Week high

6.47

52-Week change

-0.66%

Beta

0.48

50-Day moving average

1.73

200-Day moving average

2.20

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

48.56%

Operating margin

-371.48%

Operational effectiveness

Return on assets

-15.99%

Return on equity

-45.30%

Income statement

Revenue (ttm)

0.27

Revenue per share (ttm)

0.27

Quarterly revenue growth (yoy)

Gross profit (ttm)

3.29M

EBITDA

-26,883,000.00

Net income to common (ttm)

-24,183,000.00

Diluted EPS (ttm)

-0.89

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

86.80M

Total cash per share (mrq)

3.30

Total debt (mrq)

6.16M

Total Debt/Equity (mrq)

14.37

Current ratio (mrq)

639.00%

Book value per share (mrq)

1.63

Cash flow

Cash flow statement

-27,081,000.00

Levered free cash flow (LFCF)

-17,983,250.00